home / stock / admp / admp quote
Last: | $0.775063 |
---|---|
Change Percent: | 2.41% |
Open: | $0.75 |
Close: | $0.775063 |
High: | $0.789899 |
Low: | $0.75 |
Volume: | 118,557 |
Last Trade Date Time: | 09/07/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.775063 | $0.75 | $0.775063 | $0.789899 | $0.75 | 118,557 | 09-07-2023 |
$0.7685 | $0.7644 | $0.7685 | $0.795999 | $0.7601 | 99,744 | 09-06-2023 |
$0.79 | $0.7939 | $0.79 | $0.8 | $0.7505 | 100,521 | 09-05-2023 |
$0.791 | $0.7987 | $0.791 | $0.8119 | $0.7702 | 96,881 | 09-04-2023 |
$0.791 | $0.7987 | $0.791 | $0.8119 | $0.7702 | 96,881 | 09-01-2023 |
$0.8088 | $0.8122 | $0.8088 | $0.8399 | $0.79 | 82,460 | 08-31-2023 |
$0.8122 | $0.8585 | $0.8122 | $0.8585 | $0.79 | 234,334 | 08-30-2023 |
$0.8507 | $0.8887 | $0.8507 | $0.8997 | $0.8405 | 173,864 | 08-29-2023 |
$0.86 | $0.82 | $0.86 | $0.93 | $0.82 | 356,043 | 08-28-2023 |
$0.8278 | $0.781 | $0.8278 | $0.8492 | $0.77 | 267,732 | 08-25-2023 |
$0.78 | $0.7816 | $0.78 | $0.8197 | $0.78 | 274,469 | 08-24-2023 |
$0.79 | $0.783 | $0.79 | $0.8 | $0.775 | 389,528 | 08-23-2023 |
$0.8103 | $0.89 | $0.8103 | $0.9041 | $0.7711 | 605,116 | 08-22-2023 |
$0.8899 | $0.885 | $0.8899 | $0.98 | $0.8611 | 419,643 | 08-21-2023 |
$0.8926 | $0.9801 | $0.8926 | $0.9811 | $0.8235 | 756,386 | 08-18-2023 |
$1.02 | $0.7899 | $1.02 | $1.1 | $0.7805 | 3,591,571 | 08-17-2023 |
$0.7934 | $0.8843 | $0.7934 | $0.8843 | $0.77 | 906,153 | 08-16-2023 |
$0.9205 | $1.05 | $0.9205 | $1.06 | $0.9202 | 804,762 | 08-15-2023 |
$1.08 | $1.11 | $1.08 | $1.16 | $1.0205 | 788,438 | 08-14-2023 |
$1.14 | $1.16 | $1.14 | $1.2198 | $1.06 | 1,268,789 | 08-11-2023 |
News, Short Squeeze, Breakout and More Instantly...
Adamis Pharmaceuticals Corporation Company Name:
ADMP Stock Symbol:
NASDAQ Market:
Adamis Pharmaceuticals Corporation Website:
SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the company changed its name to DMK Pharmaceuticals Corporation in order to better reflect its new strategic focus on advancing sm...
SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced financial results for the second quarter ended June 30, 2023, and provided an update on recent corporate developments. Q2 2023 ...
SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the closing of its public offering of 5,930,000 units, with each unit consisting of one share of common stock (or pre-funded warrant in...